Ways of better diagnosing and treating Parkinson’s patients may lie in developing biomarkers, inhibitors, and stem cells therapies that are based on an enzyme newly identified in research into this disease, called soluble epoxide hydrolase (sEH), a commentary article suggests. The opinion piece, “Fatty acid chemical mediator provides insights…
Quantifying changes in fluid in a specific brain area, using a magnetic resonance imaging (MRI)-based method, could provide a way to track brain damage in patients with Parkinson’s disease, a new study suggests. The study, “Progression marker of Parkinson’s disease: a 4-year multi-site imaging study,” appeared in the journal Brain.
Early diagnosis and treatment of Parkinson’s disease (PD) are crucial to halting its progression, since the process of neuron destruction is irreversible once it starts. However, only 50 percent of patients are correctly diagnosed with this neurodegenerative condition during a first visit with a neurologist. An international team of researchers, led by Dr. David…
Mayo Clinic researchers in Arizona and Banner Sun Health Research Institute have found that a biopsy of a portion of a person’s submandibular gland may be a feasible approach to diagnose early Parkinson’s disease. The research is published in the journal Movement Disorders and titled “Peripheral…
Get regular updates to your inbox.
